Vancouver, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The anticipated expansion of the global urinalysis market is projected to reach a valuation of approximately USD 6.49 Billion by the year 2030. This growth is forecasted to occur at a consistent and moderate Compound Annual Growth Rate (CAGR) of 7.2%, as outlined in the latest analysis conducted by Emergen Research. The driving forces behind this market growth are multifaceted. There is an increasing prevalence of conditions such as Urinary Tract Infections (UTIs), diabetes, and various kidney diseases including Chronic Kidney Disease (CKD), polycystic kidney disease, and acute kidney failure. This escalation in health concerns has spurred the development of advanced technological solutions for urinalysis methods, which in turn aids in the early diagnosis of these ailments.
A notable contributor to market expansion is the escalating adoption of automated urinalysis across diverse medical facilities including hospitals, clinics, and other healthcare centers. This trend is bolstered by the convenience and efficiency that automated urinalysis systems bring to the diagnostic process. Furthermore, significant advancements in technology pertaining to urine analysis instrumentation have been witnessed. This encompasses the introduction of new biomarkers and an enhanced understanding of the strategic importance of urinalysis in the realm of medical science. This renewed perspective has placed emphasis on the early detection and management of kidney diseases, along with other conditions like pregnancy-related complications such as gestational diabetes.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1561
The growth of market revenue faces a notable constraint due to the availability of refurbished urine analyzers. These reconditioned analyzers offer the same functionalities as brand-new equipment but come at a reduced cost. This affordability is particularly appealing to small and medium-sized laboratories that seek cost-effective options. However, this situation also raises concerns about the preservation and transportation of urine samples to testing facilities.
During the transfer of samples, including the movement of test strips, there is a potential risk of targets of interest deteriorating. Additionally, challenges arise from the possibility of sample contamination. This contamination can arise due to suboptimal collection practices when samples are gathered. This collection process is crucial as it forms the basis for deriving results within specific time intervals and urine volumes. Hence, these factors collectively contribute to the limitation of market revenue growth. While refurbished analyzers offer economic advantages, the potential drawbacks related to sample integrity and accuracy, as well as the risk of contamination, have an impact on the overall expansion of the market.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1561
Scope of Research
Report Details | Outcome |
Market Size in 2021 | USD 3.46 Billion |
CAGR (2022–2030) | 7.2% |
Revenue Forecast to 2030 | USD 6.49 Billion |
Base Year for Estimation | 2021 |
Historical Data | 2021–2030 |
Forecast Period | 2022–2030 |
Quantitative Units | Revenue in USD Million and CAGR in % from 2022 to 2030 |
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered | Products, test-type, application, end-use, and region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. |
Country Scope | U.S., Canada, Mexico, Germany, UK, France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, Israel, and Rest of Middle East & Africa |
Key Companies Profiled | Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Cardinal Health, Abbott, Danaher, Sysmex Corporation, Thermo Fisher Scientific Inc., Quidel Corporation, BD, and Bio-Rad Laboratories, Inc. |
Customization Scope | 10 hours of free customization and expert consultation |
Major Companies and Competitive Landscape
The global urinalysis market is fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective services. Some major players included in the global urinalysis market report are:
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd.
- Cardinal Health
- Abbott
- Danaher
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Quidel Corporation
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
Strategic Development
- On 10 February 2022, Just Fitter released its 10 Parameter Urine Evaluate Strips, which provide a straightforward way to test kidney and liver function at home. Just Fitter sells a bundle of 100 reagent test strips on their website. This newly released 10 parameter test strips are intended to allow users to test their urine on a regular basis for presence of various chemicals associated with UTIs and other disorders.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1561
Some Key Highlights From the Report
- On 10 July 2021, Bisu, Inc., a Tokyo-based digital health startup that helps users to improve their fitness and wellness through at-home lab-grade testing, raised USD 3.2 million in seed funding led by Korean biotech investor QUAD, with participation from ASICS Ventures Corporation, 15th Rock Ventures, Pacifico Investments, and SOSV. Bisu Body Coach, a portable home health lab that gives personalized nutritional and lifestyle advice via easy, accurate urine and saliva testing, will be available for purchase. Bisu is also committed to work with ASICS Corporation on health and fitness service projects.
- The pregnancy and fertility segment is expected to register a high revenue growth rate during the forecast period owing to rising prevalence of infertility, as well as increasing age of first pregnancy. For example, infertility is a global health issue that affects millions of individuals of reproductive age. According to estimates, infertility affects 48 million couples and 186 million individuals globally. On the other hand, environmental and lifestyle factors, such as smoking, excessive alcohol consumption, obesity, and exposure to environmental toxins, have been associated with lower fertility rates in both men and women. As a result, market revenue growth is driven by rising prevalence of infertility and use of urinalysis during pregnancy.
- The home care settings segment is expected to register a high revenue growth rate during the forecast period. A home-use urinalysis strip allows users to monitor their health from comfort of their own homes rather than seeing a medical expert for a urine test every time they suspect an issue, which may be costly and time-consuming. Home urinalysis enhances screening uptake, such as ACR testing for diabetic and hypertensive patients and lowers frequency of GP and clinic visits, alleviating load on NHS's overworked services. As a result, aforementioned factors are expected to drive revenue growth of this segment.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/urinalysis-market
Emergen Research has segmented the global urinalysis market based on products, test type, application, end-use, and region:
- Products Outlook (Revenue, USD Billion; 2019–2030)
- Consumables
-
- Pregnancy and Fertility Kits
- Dipsticks
- Disposables
- Reagents
-
- Instruments
-
- Automated Urine Analyzers
- Biochemical Urine Analyzers
-
-
- Sediment Urine Analyzers
- Microscopy Analyzers
-
-
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Biochemical Urine Analyzers
- Semi-automated Urine Analyzers
- Point-of-Care Urine Analyzers
- Automated Urine Analyzers
-
- Consumables
- Test-Type Outlook (Revenue, USD Billion; 2019–2030)
-
- Pregnancy & Fertility Tests
- Biochemical Urinalysis
-
-
-
- Laboratory Tests
- POC Tests
-
-
-
- Sediment Urinalysis
- Application Outlook (Revenue, USD Billion; 2019–2030)
-
- Disease Screening
-
-
-
- Urinary Tract Infections
- Kidney Diseases
- Diabetes
- Liver Diseases
- Others
-
-
-
- Pregnancy and Fertility
- End-Use Outlook (Revenue, USD Billion; 2019–2030)
-
- Diagnostic Laboratories
- Hospitals and Clinics
- Home Care Settings
- Research Laboratories and Institutes
- Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of Middle East & Africa
- North America
Curated Reports You Shouldn't Miss: Dive In Now!
Cell and Gene Therapy Market By Indication (Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-Cell Lymphoma, ADA-SCID), By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus, Modified Herpes Simplex Virus, Adenovirus, Non-Viral Plasmid Vector), Forecasts to 2027
Joint Reconstruction Devices Market By Type (Knee, Hip, Shoulder, Ankle), By Technique (Joint replacement, Osteotomy, Arthroscopy, Resurfacing), By Application (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers), Forecasts to 2027
Operating Room Integration Systems Market By Device Type (Audio Video Management System, Display System, Documentation Management System), By End-Use, By Application (General Surgery, Orthopedic Surgery, Neurosurgery), Forecasts to 2027
Companion Diagnostics Market By Technology (Immunohistochemistry, In Situ Hybridization, Polymerase Chain Reaction, Genetic Sequencing), By Disease Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Skin Cancer), By Application (Hospitals, Diagnostic Laboratories), By Region, Forecasts to 2017-2027
Precision Medicine Market By Technology (Big-Data Analytics and Bioinformatics), By Application (Oncology and CNS), By End-Use (Pharmaceutical Companies and Healthcare IT Companies), and By Region Forecast to 2030
Cell Culture Market Size, Share, Trends, By Consumables (Media, Sera, Reagents), By Product (Culture Systems, Incubators, Centrifuges, Pipetting Instruments, Biosafety Equipment, Cryostorage Equipment), By Application, Forecasts to 2027
Liquid Biopsy Market, By Product Type (Assays Kits, Instruments, Services), By Circulating Biomarkers, By Sample Type, By Technology, By Disease, By Application, By End-Use, and By Region Forecast to 2030
Microfluidics Market, By Material Type (Polymer, Silicon, Glass, Others), By Application (Point-of-Care Testing, Drug Delivery Systems, Others), By Components (Microfluidic Chips, Micropumps, Microneedles, Others), and By Region Forecast to 2030
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Explore Our Japanese Version: Urinalysis Market
Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights
Read our Press Release @ https://www.emergenresearch.com/press-release/global-urinalysis-market